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Cortical dysplasia is associated with intractable epilepsy and developmental delay in young
children. Recent work with the rat freeze-induced focal cortical dysplasia (FCD) model has
demonstrated that hyperexcitability in the dysplastic cortex is due in part to higher levels
of extracellular glutamate. Astrocyte glutamate transporters play a pivotal role in cortical
maintaining extracellular glutamate concentrations. Here we examined the function of
astrocytic glutamate transporters in a FCD model in rats. Neocortical freeze lesions were
made in postnatal day (PN) 1 rat pups and whole cell electrophysiological recordings
and biochemical studies were performed at PN 21–28. Synaptically evoked glutamate
transporter currents in astrocytes showed a near 10-fold reduction in amplitude compared
to sham operated controls. Astrocyte glutamate transporter currents from lesioned
animals were also significantly reduced when challenged exogenously applied glutamate.
Reduced astrocytic glutamate transport clearance contributed to increased NMDA
receptor-mediated current decay kinetics in lesioned animals. The electrophysiological
profile of astrocytes in the lesion group was also markedly changed compared to sham
operated animals. Control astrocytes demonstrate large-amplitude linear leak currents
in response to voltage-steps whereas astrocytes in lesioned animals demonstrated
significantly smaller voltage-activated inward and outward currents. Significant decreases
in astrocyte resting membrane potential and increases in input resistance were observed
in lesioned animals. However, Western blotting, immunohistochemistry and quantitative
PCR demonstrated no differences in the expression of the astrocytic glutamate
transporter GLT-1 in lesioned animals relative to controls. These data suggest that, in
the absence of changes in protein or mRNA expression levels, functional changes in
astrocytic glutamate transporters contribute to neuronal hyperexcitability in the FCD
model.
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INTRODUCTION
Development of seizures in children is often associated with focal
cortical dysplasia (FCD; Krsek et al., 2009) with some manner of
dysplasia present in up to 40% of intractable childhood epilepsies
(Hagemann et al., 2006). These cortical malformations appear to
arise from abnormal neuronal migration during brain develop-
ment. This atypical migration leads to disruption of the cortical
cytoarchitecture and formation of microgyria and heterotopias
(D’Incerti, 2003). The mechanisms that contribute to epilepto-
genesis in patients with cortical malformations are not entirely
clear. Improper maturation of neurons (Cepeda et al., 2006)
and aberrant cortical synaptic connectivity that alter excitation-
inhibition balance may in part underlie epileptiform activity
(Zhou et al., 2009). In support of this, brain slices prepared from
human dysplastic cortex display abnormal synaptic connections
and increased excitability (Cepeda et al., 2006).
Many of the anatomical and electrophysiological characteris-
tics of human FCD are reproduced following transcortical freeze-
lesions in the newborn rat (Dvorák and Feit, 1977; Jacobs et al.,
1996; Luhmann and Raabe, 1996; Hablitz and DeFazio, 1998).
Using this well-characterized model, we and others have shown
that adjacent to the lesion is a hyperexcitable zone which displays
epileptiform discharges, alterations in neuronal NMDA receptors,
and increases in tonic NMDA receptor-mediated currents (Jacobs
et al., 1996; Campbell and Hablitz, 2005, 2008). These changes
contribute to neuronal hyperexcitability in this model. Additional
work has demonstrated that this hyperexcitability may be due
in part to higher levels of extracellular glutamate resulting from
changes in glutamate transporters (Campbell and Hablitz, 2008).
The present work tests the hypothesis that increases in extracellu-
lar glutamate ([Glu−]out) arise in part from deficits in astrocytic
glutamate uptake.
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Astrocytes are charged with removing glutamate from the
extracellular space (ECS) following neuronal activity and main-
taining [Glu−]out at low ambient concentrations. Normal brain
function demands [Glu−]out levels be kept low (1–2 µM) to
avoid receptor desensitization or excitotoxicity (Cavelier et al.,
2005). In the gray matter, this function is largely mediated by the
astrocyte specific, Na+-dependent glutamate transporter EAAT2
(GLT-1 in rodents). Under physiological conditions, experimental
evidence indicates it is difficult to overwhelm astrocytic glutamate
transporters. High frequency stimulation for prolonged periods
does not affect glutamate clearance from the ECS; Diamond and
Jahr, 2000. Astrocytes in culture, which express reduced GLT-1
relative to astrocytes in vivo, can effectively reduce glutamate to
ambient levels when challenged repeatedly with 100-fold gluta-
mate increases over physiological [Glu−]out levels (Ye et al., 1999).
Despite this, elevated levels of extracellular glutamate have long
been linked to seizures and epileptiform activity (Eid et al., 2008).
These data suggest that for glutamate to rise significantly in the
epileptic brain marked reductions in expression and or function
of glial glutamate transporters must occur.
Changes in glutamate transporter expression have been
observed in human temporal lobe epilepsy (Mathern et al., 1999;
Crino et al., 2002), neocortical epilepsy (White et al., 2001) and
tuberous sclerosis (White et al., 2001), as well as in experimental
models of epilepsy (Miller et al., 1997; Nonaka et al., 1998;
Mathern et al., 1999; Simantov et al., 1999; Crino et al., 2002).
However, the functional changes that occur when glutamate
transporter expression is altered have not been examined. Here
we hypothesized that functioning of glutamate transporters in
astrocytes would be decreased in the hyperexcitable zone adjacent
to the freeze-induced microgyrus.
METHODS
LESION INDUCTION AND SLICE PREPARATION
All experimental protocols were in accordance with the NIH
guidelines and were carried out with approval from the Animal
Care and Use Committee of the University of Alabama at Birm-
ingham. Every effort was made to minimize pain and discomfort.
Focal freeze lesions were induced in postnatal day (PN) 1 Sprague-
Dawley rat pups using methods previously described (Campbell
and Hablitz, 2008). In brief, newborn rats were anesthetized by
hypothermia (5 min on ice). A small incision in the skin was made
to expose the skull. A cooled (∼−60◦C) copper rod (diameter:
1 mm) was placed on the surface of the skull near the midline
for 3–5 s. After suturing the scalp, the animals were warmed
and returned to their home cage. Sham-operated control rats
received placement of a non-cooled rod. A recovery period of
21–28 days before further studies was used for both freeze-
lesioned and sham-operated rats.
Slices were prepared as described previously (Campbell and
Hablitz, 2008). Rats were anesthetized with isoflurane and decap-
itated. The brain was removed quickly and placed in ice-cold
saline, containing (in mM): 125 NaCl, 3.5 KCl, 0.5 CaCl2, 3.5
MgCl2, 26 NaHCO3 and 10 D-glucose. Coronal neocortical brain
slices (300 µm thick) were cut through the microgyrus and from
corresponding areas of sham-operated and littermate controls.
The slices were stored for 40–60 min at 37◦C in saline similar to
that described above but containing 2.5 mM CaCl2 and 1.3 mM
MgCl2. They were then kept at room temperature until recording.
Solutions were perfused into the recording chamber via an in-
line heater which maintained temperatures between 30–32◦C.
Astrocytes were identified based on cell morphology, lack of spon-
taneous synaptic activity and absence of action potentials. In some
instances, biocytin (Sigma-Aldrich, St. Louis, MO) was added to
the pipette solution (0.5 mg/mL) for post-hoc identification and
assessment of cell coupling.
WHOLE-CELL RECORDING
Whole-cell, voltage-clamp recordings were made from astrocytes
as described previously (Olsen et al., 2006) and pyramidal neu-
rons (Campbell and Hablitz, 2008). For astrocytes the standard
KCl pipette solution contained (in mM) 145 KCl, 1 MgCl2, 10
EGTA, 10 HEPES sodium salt, and pH was adjusted to 7.3 with
Tris-base. CaCl2 (0.2 mM) was added to the pipette solution
just before recording, resulting in a free calcium concentration
of 1.9 nM. For neurons, the intracellular solution contained
(in mM): 134 K-gluconate, 1 KCl, 10 HEPES, 2 Mg-ATP, 0.2
Na-GTP, and 0.5 EGTA. pH and osmolarity were adjusted to 7.4
and 285–290 mOsms, respectively. For all experiments described
temperature was maintained between 30–32◦C using an in-line
heater. Astrocytes were held at −80 mV and neurons were held
at−70 mV. Resting membrane potentials were measured∼1 min
after whole cell access was obtained. Recordings were made from
layer II/III pyramidal cells, chosen on the basis of their depth
below the pial surface and location (0.3–1.5 mm lateral to the
microsulcus). Series resistance and input resistance were carefully
monitored during each experiment with a 10 mV hyperpolarizing
voltage step. During astrocyte recordings whole-cell capacitance
and series resistances were also measured directly from the ampli-
fier, with the upper limit for series resistance being 12 MΩ and
series resistance compensation adjusted to 80% to reduce voltage
errors.
Evoked synaptic currents were recorded from pyramidal neu-
rons and synaptic glutamate transporter currents (STCs) were
recorded from astrocytes. Currents were evoked with a bipolar
stimulating electrode (twisted pair of 25 µm Formvar insulated
nichrome wires) positioned within 150–200 µm of the recording
pipette. Current pulses 10–100 µA in amplitude and 50–100 µs
in duration were used. A stimulation frequency of 0.05 Hz was
used. Unless stated otherwise, all records of synaptic transporter
currents shown represent the average of 10 consecutive responses.
Control responses were recorded from astrocytes voltage clamped
at −80 mV. TBOA (30 µM) and DHK (300 µM) were subse-
quently bath applied.
Exogenous glutamate was applied using a Picospritzer
(Warner, Hamden, CT) as described previously (Gonzalez-Islas
and Hablitz, 2003). Glutamate responses were recorded in astro-
cytes voltage-clamped at −80 mV in a saline containing 500 nM
TTX, 100 µM CdCl2, 50 µM CNQX, 20 µM bicuculline and 50
µM AP5 to isolate glutamate transporter currents (Bergles and
Jahr, 1997). A 500 msec puff of glutamate (500 µM) was pressure
applied onto the voltage clamped astrocyte. The puffing solution
contained 120 mM NaCl, 3.5 mM KCl, 1.3 mM MgCl2, 2.5
mM CaCl2, 25 mM HEPES, 10 mM glucose, 500 µM glutamate,
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500 nM TTX, 100 µM CdCl2, 50 µM CNQX, 20 µM bicuculline
and 50 µM AP5 (pH adjusted to 7.4). The puffer pipette was
placed in the same focal plane as the voltage clamped cell and
manipulated until a maximum response was elicited. Astrocytic
responses were not observed in control experiments when gluta-
mate was omitted from the pipette solution. All traces shown are
the average of 3 or more consecutive applications of glutamate.
To isolate NMDA receptor-mediated EPSC’s (excitatory post-
synaptic currents) bicuculline (10 µM) and CNQX (20 µM)
were added to the ACSF bathing solution. Layer II/III pyramidal
neurons were stepped from a potential of −70 mV to +50 mV
and NMDA receptor- mediated currents were evoked with a
bipolar stimulating electrode positioned within 150–200 µm of
the recording pipette (Layer IV/V). Current pulses 10–100 µA
in amplitude and 50 µs in duration were used. A stimulation
frequency of 0.05 Hz was used. For these experiments a cesium
based internal solution was used which contained in mM: 130
CsCl, 10 EGTA, 2 MgATP, 10 HEPES, 0.2 mm NaGTP, 5 mm
QX314, pH adjusted to 7.3 with CsOH and an osmolarity of∼284
mOsms. TBOA (50 µM) was bath applied. All traces shown are
the average of 3 or more traces.
DRUGS
D-(−)-2-amino-5-phosphonovaleric acid (D-APV), DL-threo-β-
benzylozyaspartic acid (TBOA) tetrodotoxin (TTX), 6-Cyano-
7-nitroquinoxaline-2,3-dione (CNQX), bicuculline (Bic),
memantine and dihydrokainic acid (DHK) were purchased from
Tocris Bioscience (Ellisville, MO, USA). These drugs were stored
in frozen stock solution and dissolved in saline prior to each
experiment. All other chemical and drugs were purchased from
Sigma-Aldrich.
WESTERN BLOT ANALYSIS
Thick (0.7–1 mm) neocortical coronal brain slices containing
the microgyrus and corresponding areas of sham-operated lit-
termate controls were obtained. Coronal slices allowed for easy
identification of the midline, microsulcus and the hyperexcitable
zone. The corpus callosum also served as a landmark. Great
care was taken to ensure punches were collected from equivalent
regions in lesioned and sham operated animals. Tissue punches
(1 mm diameter) were obtained from the microsulcus, the hyper-
excitable region and the contralateral cortex and placed in ice
cold homogenization buffer (100 mM Tris, pH 7.5, 1% SDS)
supplemented with protease and phosphatase inhibitors (Sigma).
The tissue was mechanically homogenized and then sonicated for
10 s. Tissue homogenates were centrifuged for 5 min at 12,000 g
at 4◦C. Protein quantification was performed on the supernatant
using a DC protein assay kit from Bio-Rad (Hercules, CA).
Protein was heated to 60◦C for 15 min in an equal volume
of 2X sample buffer (100 mM Tris, pH 6.8, 10% SDS in
Laemmli-sodium dodecylsulfate, 600 mM β-mercaptoethanol).
Equal amounts of protein were loaded into a 4–20% gradient pre-
cast SDS gel (Bio-Rad). Gels were transferred using a constant
200 mA current for 2 h at room temperature. Membranes then
were blocked in blocking buffer (10% dried milk in TBST). After
three 10 min washes, membranes were developed with enhanced
chemiluminesence (Amersham, Arlington Heights, IL) using an
Image Station 4000 MM (Kodak). The blots were then stripped
and re-probed with GLT-1 guinea pig (1:10,000), GFAP mouse
(1:5,000; Millipore) and gapDH mouse (Abcam 1:1000) or actin
rabbit (Sigma) antibodies for a loading control. Protein expres-
sion was quantitated using the Kodak Image Station normalizing
total GLT-1 or GFAP protein to gapDH or actin expression in the
same lane. Relative amounts of protein are reported.
QUANTITATIVE PCR
Tissue punches were obtained as described above. The tissue was
homogenized in a glass homogenizer with 800 µL of RNA STAT
60 (Friendswood, TX). Total RNA was isolated using the protocol
described. The total RNA was diluted to a final concentration
of 1 ug/uL and converted to cDNA using the VILO Superscript
kit from Invitrogen. Quantitative real-time PCR using TaqMan
specific probes for GLT-1, GFAP, CNX 43 and gapDH (Applied
Biosystems) in 3 control and 6 injured animals were performed.
All probes used throughout this study span exon boundaries and
as such only amplify mRNA. Each sample was run in triplicate,
and normalized to gapDH, and the comparative Ct method was
used to calculate changes in gene expression.
IMMUNOHISTOCHEMISTRY
Animals were anesthetized with an intra-peritoneal injection of
ketamine (100 mg/kg) and perfused with a 4% paraformaldehyde
solution for 30 min. The brain was removed and stored in 4%
paraformaldehyde. After washing in PBS, 50 µM neocortical
sections containing the microgyrus and corresponding sections
in sham operated animals were cut using a Vibratome (Oxford
Instruments). Sections were blocked for 1 h in 10% horse serum
and 0.3% Triton-X100 in PBS (PBS). Primary antibodies were
diluted in blocking buffer (1:3 solution with PBS) and incu-
bated with slices overnight. The sections were then washed three
times in diluted PBS incubated with FITC or TRITC-conjugated
secondary antibodies obtained from Molecular Probes for 60 min
at room temperature. The slices were then washed two times with
diluted PBS, incubated with DAPI (10–4 mg/ml; Sigma), and
finally washed two times with PBS before being mounted onto
glass coverslips. Fluorescent images were acquired with a Zeiss
Axiovert 200 M. Confocal images were acquired on an Olympus
Confocal FV 300 (Center Valley, PA). Distances from the pial
surface and the midline to the hyperexcitable zone were used
as landmarks for image acquisition. Similar measurements were
used in control animals to ensure images were obtained from
similar regions.
STATISTICAL ANALYSIS
Current responses to various voltage step and ramp protocols
were analyzed and measured in Clampfit 8.0 (Molecular Devices).
The resulting raw data were graphed and plotted in Origin 8.5
(MicroCal, Northampton, MA). When comparing 2 groups, two-
tailed t-tests were performed as appropriate. All data are reported
as average ± standard error of the mean with an asterisk (∗)
indicating that p ≤ 0.05. Statistical analysis was performed using
GraphPad software (San Diego, CA), and p-values are reported
in the text. Current amplitudes are reported as mean ± SE,
with n indicating the number of cells sampled. For western blot
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quantification, the relative amount of Kir4.1 protein in each lane
was normalized to its loading control and then normalized to the
total amount of protein in control lanes. The data are reported
as mean ± SE with n indicating the number of animals per
condition.
RESULTS
NEURONAL HYPEREXCITABILITY IN THE LESIONED CORTEX IS
DEPENDENT ON REDUCED ASTROCYTE GLUTAMATE UPTAKE
A representative image of a cresyl violet stained cortical brain
slice from a lesioned animal 24 days post lesion is shown in
Figure 1A. The region adjacent to the microgyrus (a distance
of 0.5 mm–2.5 mm, circled in black) has been termed hyper-
excitable zone (Jacobs et al., 1996; Luhmann and Raabe, 1996).
Neurons from this region display a lower threshold for evoking
epileptiform activity and when stimulated have the capacity to
generate abnormal electrical activity that spreads to surrounding
tissue in the cortex (Jacobs et al., 1996; Luhmann and Raabe, 1996;
Hablitz and DeFazio, 1998). The occurrence of these long lasting
epileptiform discharges in the lesioned cortex are produced by
a complex pattern of excitatory and inhibitory inputs (DeFazio
and Hablitz, 2000). More recently, it has been demonstrated that
the observed hyperexcitability is due in part to higher levels
of extracellular glutamate which can be abrogated by blocking
neuronal NMDA receptors (Campbell and Hablitz, 2008). Here
we tested the notion that elevated glutamate is due in part to
deficient astrocyte mediated glutamate clearance. In the first
set of experiments we compared the currents elicited layer 2/3
pyramidal neurons in sham-treated slices when glutamate trans-
porters were blocked with TBOA to those elicited in lesioned
cortex neurons in normal ACSF. A brief electrical stimulation
(50 us, 100 µA) applied in deeper cortical layers IV/V that
was four times the stimulation required to elicit a threshold
response was used. This was to ensure that only large current
responses were induced, where glutamate transporter function
would more likely be challenged (Campbell and Hablitz, 2004,
2008). In slices from sham treated animals, stimulation induced
large responses in layer II/III pyramidal neurons with a mean
response area of 1327 ± 125 pA*ms (n = 15 slices, Figure 1B).
Bath application of TBOA (30 µM) significantly prolonged the
response area (5081 ± 872 pA*ms, n = 15 slices, p < 0.001).
Using the same stimulation protocol (four times the threshold)
we elicited responses in the hyperexcitable zone of the lesioned
cortex, which induced current responses with similar response
area (3961± 872 pA*ms, n = 12 slices, p> 0.05) when compared
to the response area in the sham slices in the presence of TBOA.
When glutamate uptake was inhibited (TBOA 30 µM) in the
lesioned cortex there was a pronounced increase in the response
area (59214± 13271 pA*ms, n = 12 slices, p< 0.05) of the evoked
epileptiform activity. This prominent increase in the response area
in lesioned slices was independent of the initial stimulus intensity,
since both low and high stimulus evoked events resulted in a
marked prolongation of epileptiform activity (data not shown).
To more directly assess the role of excess glutamate on neu-
ronal excitability, we isolated NMDA receptor-mediate currents
in control and lesioned animals in layer II/III pyramidal neurons
(Figure 2). Here, neurons were stepped from a holding potential
of−70 mV to +50 mV to remove the Mg2+ block. Stimulation in
layer IV/V elicited outward NMDA receptor-mediated currents.
Current decay for all 13 sham-operated neurons and 14 lesioned
neurons were best fit by a sum of two exponentials. Represen-
tative, normalized traces demonstrate that the slow component
of the decay (τ slow) was significantly increased in the lesioned
animals relative to sham-operated littermates (Figure 2A). Here
the τ slow 279.3 +/− 16.3 in sham vs. 375.8 +/− 36.4 in lesioned
animals (n = 13 sham-operated, n = 14 lesion, p = 0.0266,
Figure 2B), suggesting prolonged glutamate in the ECS in the
lesioned cortex following stimulation. Histograms of τ slow indi-
cate a greater number of cells in bins with larger τ values for
the lesion group (Figure 2C). Although a trend was observed,
there was no significant difference in the fast component of
the NMDA decay constant (τ fast) between sham-operated and
lesioned animals (66.7 +/− 10.3 (n = 13) and 96.9 +/− 14.3
(n = 14)). Application of TBOA to block astrocytic glu-
tamate transporters significantly increased the τ slow in both
sham and lesioned animals (Figures 2B–D, 484.5 +/− 51.9
(n = 7) vs. 609.3 +/− 76.7 (n = 8), respectively) relative to ACSF.
However, here was no statistical difference between the decay
kinetics in sham and lesioned animals in the presence of TBOA
(Figure 2B, p = 0.2142). There was also no difference observed
in the fast component of the NMDA receptor-mediated current
decay constant (τ fast) between sham-operated and lesioned ani-
mals in the presence of TBOA (123.2 +/− 27.2 and 139.0 +/−
29, respectively). Together, these results suggest that the increased
excitability in the lesioned cortex is due, in part to elevated
glutamate levels resulting from alteration in glutamate transporter
function.
ALTERED ELECTROPHYSIOLOGICAL PROPERTIES IN HYPEREXCITABLE
ZONE ASTROCYTES
To examine the contribution of astrocytic glutamate transporter
dysfunction in the lesion cortex we first investigated the prop-
erties of the astrocytes in the hyperexcitable zone of lesioned
cortex. Astrocytes recordings obtained from sham-treated ani-
mals, displayed large-amplitude, linear currents typical of passive
astrocytes (Zhou et al., 2006), as shown in Figure 3A. Similar
results were obtained in 15/15 astrocytes from sham-operated
animals. In contrast, 13/16 astrocytes from the hyperexcitable
zone of lesioned animals displayed prominent voltage-gated cur-
rents (Figure 3B). The inset shows currents at higher resolution.
We also analyzed the response to voltage ramps. Large linear
currents were elicited from control cells in response to a voltage
ramp, as shown in the current-voltage plot in Figure 3C. Currents
from astrocytes in the lesioned area were significantly smaller in
amplitude and demonstrated pronounced voltage dependance.
As shown in Figure 3D, peak inward currents at −140 mV
in astrocytes from lesioned animals were significantly decreased
compared to control (lesioned −1530 ± 373 pA, n = 16 vs.
−5297 ± 471 pA, control, n = 15, p < 0.05). This decrease
did not appear to be due to a change in cell coupling as no
differences in the number of coupled cells between the two groups
of astrocytes were observed (lesioned, n = 23.1± 2.8 vs. sham,
n = 20.8 ± 3.4, p > 0.05). Supporting this, connexin 43, the
primary connexin expressed in astrocytes, was not significantly
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FIGURE 1 | Synaptic responses in pyramidal cells in slices from sham
and lesioned animals. (A) Representative image of a cresyl-violet stained
slice from a lesioned animal showing the microsulcus. Dotted circle indicates
the hyperexcitable zone. (B) Sample traces of evoked synaptic responses
from a sham operated and lesioned animal. Responses obtained in (top: left
to right) sham ACSF, sham after TBOA (30 µM) application, lesion neuron in
ACSF and lesion neuron after TBOA (30 µM) application are shown. Bar
graphs show quantification of the synaptic current response area following
stimulation in sham and lesioned slices before and after TBOA application.
Scale bar represents 200 pA and 500 mS.
FIGURE 2 | Kinetics of NMDA receptor-mediated EPSCs are altered in
layer II/III pyramidal neurons in lesioned cortex relative to
sham-operated littermates. (A) Representative traces (each recording is
the average of 3 traces) indicate slowed NMDA receptor-mediated EPSC
decay kinetics in lesioned animals. (B) Mean data from 13 sham and 14
lesioned neurons demonstrates a significant increase in τ slow in neurons
from the lesioned cortex relative to sham littermate controls.
(C) Histograms of τ slow indicate a greater number of cells in bins with larger
τ values for the lesion group. (D) Representative traces showing no
difference the NMDA response between the sham and lesioned neurons in
the presence of TBOA (50 µM). (E) Mean data from 7 sham and 8 lesioned
neurons indicate TBOA has a similar effect on the τ slow NMDA receptor
kinetics. (F) Histograms of τ slow in TBOA indicate no difference between
sham and lesion in τ bins.
reduced in lesioned cortex as assessed by qPCR (data not shown).
This difference is attributable to a decrease in leak current in
hyperexcitable zone astrocytes. Consistent with a reduced leak
current, the input resistance in astrocytes from lesioned animals
was significantly higher relative to astrocytes from sham-operated
animals (90.9 ± 13 M, lesioned, n = 7 vs. 19 ± 5 M, controls,
n = 8, p < 0.05, Figure 3E). The resting membrane potential
(RMP) in astrocytes from lesioned slices also was significantly
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depolarized compared to those in controls (−71 ± 1.4 mV,
lesioned, n = 40 vs. −77 ± 0.8 mV, control, n = 28, p < 0.05,
Figure 3F).
REDUCED TRANSPORTER CURRENTS IN HYPEREXCITABLE ZONE
ASTROCYTES
Thus far we have demonstrated that the neuronal response in
lesioned animals in the hyperexcitable zone is similar to the
response in sham treated animals in the presence of TBOA.
We have also demonstrated that the NMDA receptor-mediated
currents are significantly slower in lesioned animals, suggesting
altered glutamate transport contributes to these differences. Fur-
thermore, we have shown that astrocytes have markedly differ-
ent electrophysiological properties in the hyperexcitable zone. In
the next set of experiments, we examined astrocyte glutamate
transporter currents in sham and lesioned animals. Release of
glutamate from synaptic terminals can be detected in astrocytes
by recording synaptically activated transporter currents (STCs;
Mennerick and Zorumski, 1994; Bergles and Jahr, 1997; Diamond
et al., 1998). STCs were evoked using a bipolar stimulating elec-
trode located subjacent to the recorded astrocyte. Astrocytes in
superficial cortical layers were voltage clamped at −80 mV and
recordings were collected in saline containing 100 µM BaCl2 to
block KIR currents (Newman, 1993; Olsen et al., 2006). Sample
recordings of currents evoked in an astrocyte from a sham-
operated animal are shown in Figure 4A. In response to single
shock stimulation, an inward current was observed. This response
was completely blocked by TBOA (30 µM), identifying the cur-
rent as a STC. When recordings were made in astrocytes located in
the hyperexcitable zone (Figure 4B), responses were significantly
smaller in amplitude and duration. STCs in these astrocytes were
also blocked by TBOA. As shown in Figure 4C, STC amplitudes in
lesioned animals were significantly smaller than those recorded in
control astrocytes (568 ± 53 pA, n = 3 control animals, n = 10
slices with one cell per slice vs. 62 ± 24 pA, n = 4 lesioned
animals, n = 12 slices with one cell per slice, p < 0.001). Two
Na+ dependent glutamate transporters, GLT-1 and GLAST, have
been identified in astrocytes with GLT-1 being the predominant
transporter expressed in gray matter astrocytes (Rothstein et al.,
1996; Tanaka et al., 1997; Regan et al., 2007), and accounting for
over 90% of glutamate uptake (Tanaka et al., 1997). TBOA is non-
specific, blocking both GLT-1 and GLAST in astrocytes. There-
fore we repeated these experiments in sham-operated astrocytes
using the GLT-1 specific inhibitor, DHK (300 µM). These data
demonstrate that STC amplitudes were reduced by 92.8 +/− 3.3%
(n = 4) by TBOA, whereas 88.6 +/− 6.7% (n = 3) of current was
inhibited by DHK (Figure 4D). These data indicate that nearly all
the synaptically evoked transporter current is mediated by GLT-1.
Several factors, including alterations in local cortical con-
nections in the dysplastic cortex, differences in threshold for
synaptic activation and/or release properties, and changes in
the astrocyte morphology could contribute to the differences in
STC amplitudes described above. Therefore, we next examined
astrocyte responses to exogenously applied glutamate. For these
experiments, recordings were obtained in the presence of 500 nM
TTX, 100 µM CdCl2, 50 µM CNQX, 20 µM bicuculline and
50 µM AP5 to minimize neuronal activity, release of endogenous
glutamate and isolate glutamate transporter currents (Bergles and
Jahr, 1997; Grass et al., 2004). Glutamate (500 µM, 500 msec)
was pressure applied to astrocytes voltage clamped at −80 mV.
The puffer pipette was visually placed in the same focal plane as
the voltage clamped cell at a distance that elicited a maximum
response. Specimen records from 8 control astrocytes (upper)
and 7 astrocytes from the lesioned cortex (lower) are shown
superimposed in Figure 5A. The average of these responses across
cells is shown in Figure 5B. There was no statistical difference in
cell size between the two groups, as measured by cell capacitance
(control 21 ± 3 pF and lesion 23 ± 4pF, p > 0.05). The changes
in STC current and glutamate uptake currents were nearly
10-fold smaller in lesion animals relative to sham operated ani-
mals. Normalizing glutamate transporter current to whole cell
capacitance, which measures the amount of current flow per unit
area of membrane, we observed transporter currents were signif-
icantly less in the hyperexcitable zone relative for that observed in
sham operated animals (1.5± 0.46 pA/pF, n = 7, lesioned vs. 21.6
± 4.8 pA/pF, n = 8, control, p< 0.05, Figure 5C). These data sug-
gest that glutamate accumulation during epileptiform discharges
in lesioned cortex would be less effectively cleared by astrocytes.
GLUTAMATE TRANSPORTER PROTEIN AND MRNA EXPRESSION IS
UNCHANGED IN THE HYPEREXCITABLE ZONE
The observed decreases in STCs and responses to exogenously
applied glutamate suggest a functional decrease in the ability
of transporters to take up extracellular glutamate. Although
functional glutamate transporter currents have not been directly
examined in models of FCD, previous work has examined gluta-
mate transporter expression with variable results (Proper et al.,
2002; Ulu et al., 2010). We therefore examined GLT-1 protein and
mRNA expression.
A 1 mm diameter tissue punch was used to obtain cortical
samples 0.7–1 mm thick from the hyperexcitable zone in lesioned
animals and comparable areas in sham operated controls. A repre-
sentative western blot is shown in Figure 6A. GLT-1 immunoreac-
tivity was unchanged in the hyperexcitable zone relative to tissue
from sham-operated controls. Quantification from four sets of
animals is shown in Figure 6B. These results demonstrate there
is no significant difference in GLT-1 protein expression between
the hyperexcitable zone of lesioned animals and sham tissue when
normalized to a loading control.
The lack of any appreciable decrease in GLT-1 protein expres-
sion prompted us to explore the possibility that a mislocalization
of GLT-1 protein was responsible for the profound reduction in
astrocyte glutamate uptake currents. As a first step, we performed
wide-field fluorescent microscopy to examine GLT-1 expression
in lesion and sham animals. We were unable to detect discernible
changes in GLT-1 expression at the hyperexcitable zone relative
to surrounding regions by wide field fluorescent microscopy
(Figure 6C). No significant differences were observed using high
powered confocal microscopy comparing GLT-1 expression pat-
terns in hyperexcitable zone from lesion and sham operated
animals (Figure 6D).
In a separate cohort of animals, tissue punches were collected
from the same region for mRNA extraction and quantitative
PCR studies. qPCR results indicated there was no significant
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difference in GLT-1 (SLC1A2) transcripts between sham operated
and lesioned animals (Figure 6E). We also observed no significant
difference in GLAST (SLC1A3) mRNA expression in the hyperex-
citable zone relative to that observed in sham-operated animals
(Figure 6F). GFAP mRNA expression, however, was significantly
elevated in the lesioned animals hyperexcitable zone (1.5 fold
relative to sham operated animals, Figure 6G). Expression of
GFAP mRNA was elevated to a much higher extent at the lesion
itself (7-fold increase over control, data not shown). While not
exhaustive, these data, together with protein expression and
immunohistochemistry data suggest there are no gross differences
in GLT-1 expression levels.
DISCUSSION
In the present study, we demonstrate that astrocytes in slices from
dysplastic neocortex display decreased glutamate transporter cur-
rents in response to both synaptic stimulation and direct appli-
cation of glutamate. Additionally, astrocytes in the hyperexcitable
zone display altered biophysical properties, including significantly
depolarized RMPs, higher input resistances and reduced leak cur-
rents. Biochemical studies, however, did not indicate differences
in GLT-1 expression. These data provide evidence for functional
changes in glutamate transporter function in dysplastic cortex.
These alterations could contribute to elevated extracellular glu-
tamate levels and hyperexcitability in cortical dysplasia.
CHANGES IN ASTROCYTE BIOPHYSICAL PROPERTIES
Distinct patterns of currents are found in hippocampal
(D’Ambrosio et al., 1998; Zhou and Kimelberg, 2000; Zhou
et al., 2006) and neocortical astrocytes (Bordey et al., 2001).
One population of glial cells demonstrates nearly linear current-
voltage (I-V) relationships whereas another group displays out-
wardly rectifying I-V curves. Astrocytes with voltage activated
inward and outward currents are observed more frequently earlier
in postnatal development (Zhou et al., 2006). The presence of
a linear I-V curve appears to be an intrinsic astrocyte prop-
erty and not dependent of gap junction development (Schools
et al., 2006). In the present study, linear currents typical of
passive astrocytes were seen in recordings from control ani-
mals whereas voltage-dependent currents were prominent in the
lesioned group (>80%). This was not due to differences in cou-
pling as measured by dye coupling or connexin expression in
the lesioned group. The observed decrease in leak currents and
associated increase in input resistance may have allowed detection
of previously obscured voltage-dependent currents in the dys-
plastic cortex. Numerous studies have attempted to identify the
“leak” or “passive” current that dominates the K+ conductance
in mature astrocytes. The primary candidates are the weakly
rectifying (TWIK)-related acid sensitive K+ channel, TASK-1,
the two-pore domain K+ channels (K2P) TWIK-1 and TREK-
1 and the weakly rectifying potassium channel Kir4.1. Using
FIGURE 3 | Astrocytes in the hyperexcitable zone display altered
electrophysiological properties. (A) Representative whole-cell current
responses to a voltage step protocol in an astrocyte in a slice from a
sham-operated control and (B) a recording obtained from an astrocyte in slice
from a lesioned animal. Inset shows current displayed at higher resolution.
(C) Representative whole-cell currents from sham-operated (black) and
lesioned (blue) astrocytes in response to a linear voltage ramp (−160 to
+160 mV). (D) Bar graph showing differences in the mean current amplitude
obtained from the voltage step protocol (at −140 mV) in control and lesioned
astrocytes. (E) Bar graph showing the input resistance in astrocytes in
lesioned animals was significantly higher (90.9 ± 13 M) than that of control
animals (19 ± 5 M). (F) The resting membrane potential was significantly
depolarized in astrocytes from lesioned animals (−71 ± 1.4 mV) relative to
control astrocytes (−77 ± 0.77 mV).
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FIGURE 4 | Synaptically evoked glutamate transporter currents (STCs)
are markedly reduced in astrocytes in lesioned animals. (A) Specimen
records showing evoked responses from a L2/3 astrocyte in a slice from a
sham-operated animal following stimulation in cortical L4/5. Responses
before and after bath application of TBOA are shown superimposed. TBOA
effectively blocked the response. Each trace is average of ten consecutive
responses. Experiments were performed in the presence of BaCl2 (100
µM) to inhibit a K+ uptake currents. (B) Similar to A, but from an astrocyte
in a slice from a lesioned animal. Specimen records show that responses
were smaller in amplitude relative to controls. Responses were TBOA
sensitive. (C) Summary plots showing differences in STCs between
astrocytes in slices from sham-operated and lesioned animals. STCs were
significantly smaller in astrocytes from lesioned slices relative to astrocytes
from sham-operated animals. (D) TBOA inhibited 92.8 +/− 3.3% (n = 4) of
STC mediated currents while 88.6 +/− 6.7% (n = 3) of current was inhibited
by DHK.
a bacterial artificial chromosome (BAC) transgenic mouse line
where EGFP expression is directly related to Kir4.1 promoter
activity, Tang et al. demonstrated a relatively large contribution
(>60%) of the overall passive current in attributable to Kir4.1
(Tang et al., 2009). Interestingly this was observed only when gap
junction communication was inhibited. Heterologously expressed
TWIK-1 and TREK-1 channels, share many of the pharmaco-
logical characteristics of the passive conductance observed in
hippocampal astrocytes including inhibition with quinine, mod-
erate inhibition by low extracellular pH, and a low sensitivity
to Ba2+ (Zhou et al., 2009). It was proposed that a disulfide
linked heterodimer of TWIK-1 and TREK-1 may be responsi-
ble for the large leak conductance in astrocytes (Hwang et al.,
2014). However, a recent study using TWIK-1 knockout mice
indicated that TWIK-1 contributes little to the whole cell cur-
rent as it is largely retained in intracellular compartments or
organelles. Only ∼5% of the total TWIK protein is trafficked
to the plasma membrane (Wang et al., 2013). Finally, TASK
channels were recently ruled out as a molecular candidate due
to differences in pharmacology between astrocyte currents in
hippocampal slices and that which has been previously reported
for TASK channels (Chu et al., 2010). Given the overlapping
pharmacology and similar biophysical characteristics of leak or
weakly rectifying potassium channels that mediates these large
amplitude currents in astrocytes we did not pursue the molec-
ular identification of the channel. Although K+ currents were
not the focus of this study, we believe the loss of the leak
current warrants future investigation as the reduced inward K+
current in astrocytes from lesioned slices likely has a signifi-
cant effect on the ability of astrocytes to take up potassium
ion from the ECS contributing to overall neuronal excitabil-
ity. Previous studies have indicated that astrocytes respond to
neuronal activity or stimulation with large amplitude inward
currents that can be dissected into two components with different
kinetics; a fast glutamate uptake component and a relatively
slow potassium uptake component (Olsen, 2012; Sibille et al.,
2014). The potassium uptake currents comprise the majority of
the astrocytic response and are mediated by barium-sensitive
Kir4.1 mediated current (Sibille et al., 2014). We have pre-
viously shown that the amplitude of the inward K+ current
is directly proportional to efficiency of K+ uptake by these
cells (Olsen et al., 2007). It can be surmised that the loss
of the leak conductance from astrocytes in the lesioned ani-
mals would contribute to increased overall excitability, espe-
cially when coupled with elevated or dysregulated extracellular
glutamate.
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FIGURE 5 | Astrocyte responses to exogenously applied glutamate are
reduced in lesioned cortex. (A) Specimen records of glutamate evoked
currents from astrocytes in slices from sham-operated (upper) or lesioned
(lower) animals. Cells were voltage clamped at −80 mV and responses were
evoked by a 500 µM, 0.5 s puff of glutamate. Bathing and puffing solutions
contained 50 µM TTX, 200 µM AP5, 200 µM bicuculline, 250 µM CNQX and
100 µM CdCl. (B) Same data as in A but responses averaged across cells are
shown. (C) Summary histogram showing that glutamate evoked responses,
normalized for cell capacitance, were significantly reduced in the lesioned
group.
CLEARANCE OF GLUTAMATE FROM THE EXTRACELLULAR SPACE
The clearance of glutamate from the ECS following neuronal
activity and the resultant curtailment of glutamatergic transmis-
sion occurs primarily via the Na+-dependent glutamate trans-
porters GLAST/EAAT1 and GLT-1/EAAT2. GLT-1 and GLAST
are preferentially but differentially expressed in astrocyte popu-
lations throughout the CNS. In adult cortical gray matter, GLT-
1 mediates the majority of glutamate clearance (Rothstein et al.,
1996; Tanaka et al., 1997; Regan et al., 2007). Protein expression
and mRNA transcripts for GLT-1 in astrocytes increase robustly
from birth to young adulthood (P0–P30). In rodents, the most
significant increases in GLT-1 expression occur during the first
two postnatal weeks (Furuta et al., 1997; Regan et al., 2007). Cor-
respondingly in humans, the most significant increase in EAAT2
occurs postnatally before 2 years of age (Lauriat et al., 2007b).
Glutamate uptake is achieved against a∼1000-fold concentra-
tion gradient between [Glu−]out and [Glu−]in. This is achieved
by coupling glutamate transport to Na+ and K+ transport down
their respective concentration gradients and the hyperpolarized
astrocyte membrane potential (Anderson and Swanson, 2000).
Given that in our experiments the astrocyte membrane was
voltage-clamped at −80 mV, the changes in membrane poten-
tial observed in astrocytes from the dysplastic cortex cannot
account for the observed reduction in glutamate transporter
currents. However, the depolarized membrane potential of astro-
cytes in lesioned animals could contribute to reduced glutamate
uptake.
Our data clearly indicate significant alterations in glutamate
transporter function. We observed a near 10-fold reduction in
TBOA sensitive transporter function. Furthermore, application
of DHK, a GLT-1 specific non transportable inhibitor, suggests
∼90% of the currents in both sham-operated and lesioned
astrocytes are mediated by GLT-1. Application of the same
concentration of glutamate in puffing experiments ruled out
the possibility that the reduced glutamate transporter responses
in the lesioned astrocytes were the result of less glutamate
release following stimulation in lesioned animals. Inefficient
clearance of glutamate by astrocytic glutamate transports fol-
lowing electrical stimulation contributed to an enhanced hyper-
excitability in the dysplastic cortex, which can be explained
in part by altered kinetics of the NDMA receptor-mediated
currents.
We postulated that the loss in GLT-1 transporter function
would be paralleled by decreased protein and mRNA expression.
To our surprise, this is not what we observed. Given our data,
it seems likely that a change in transporter effectiveness may
underlie the observed decreases in evoked transporter currents.
The activity of glutamate transporters is affected by a variety of
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FIGURE 6 | GLT-1 protein and mRNA expression levels were unchanged
in the lesioned animals. (A) A representative Western blot demonstrating
no change in GLT-1 expression in the hyperexcitable zone of lesioned tissue
relative to tissue obtained from the same region in sham-operated animals.
These blots were also stripped and re-probed with gapDH as a loading
control and the astrocyte intermediate filament GFAP. (B) Plot of relative
GLT-1 expression in lesioned tissue relative to control tissue. GLT-1
expression is normalized to the loading control gapDH. No significant
difference was observed. (C) Wide field fluorescent microscopy was used to
image the lesion, hyperexcitable zone and surrounding areas. No gross
changes in GLT-1 expression were observed (scale bar = 100 µm).
(D) Confocal imaging from a z-stack (60 sections, 1 µm/section) from the
hyperexcitable region indicating GLT-1 immunoreactivity in a sham operated
and lesioned animal (scale bar = 50 µm). (E) mRNA expression of GLT-1
(SLC1A2) was also unchanged in the hyperexcitable zone from lesioned
animals when compared to tissue obtained from sham-operated animals
(each sample ran in triplicate). (F) GLAST mRNA levels were not significantly
different between groups. (G) GFAP expression was significantly elevated in
the hyperexcitable zone (1.6 fold) relative to control tissue obtained from the
same region.
neuromodulators and second messenger systems. Decreases in
transporter activity are induced by caffeine (Shin et al., 2013)
and neurosteroids (Kang et al., 2010; Na et al., 2012) whereas
pregabalin increases responsiveness (Ryu et al., 2012). Gluta-
mate uptake in astrocytes has been shown to be potentiated
by selective pharmacological stimulation of a transgenic Gq G-
protein coupled receptor targeted specifically to astrocytes and
activation of mGluRs on astrocytes enhances STCs (Devaraju
et al., 2013). It should be noted that several splicing isoforms of
GLT-1 have been identified, including multiple 5′ splice variants
(Rozyczka and Engele, 2005) and isoforms in which entire exons
are deleted (Lauriat et al., 2007a). The antibodies and qPCR
probes used in this study would not have delineated between
different spice variants which may exhibit functional differences
in uptake. Furthermore, alterations in signaling molecules such
as PKC, which alter GLT-1 trafficking to the plasma mem-
brane (Kalandadze et al., 2002) may occur in the hyperex-
citable zone. While our immunohistochemical studies indicate
no gross changes in GLT-1 transporter immunoreactivity, they
do not address transporter localization, or significant changes
in astrocyte morphology that may affect glutamate import.
Another possibility is that the conditions in the dysplastic
cortex are favorable for glutamate transporters to function in
reverse. Traditionally, application of extracellular K+ has been
used to study reverse glutamate transport (Szatkowski et al.,
1990) In the lesioned cortex, during epileptiform discharges
there is elevated extracellular glutamate levels leading to elevated
extracellular K+, coupled with our reported depolarized mem-
brane potential in glia cells would create the perfect environ-
ment for transporters to function in reverse (Brew and Attwell,
1987). Indeed studies have shown that reverse glutamate trans-
port occurs under some pathophysiological conditions including
brain ischemia (Rossi et al., 2000). Our data shows that block-
ing glutamate transporters in the lesioned cortex exacerbated
evoked epileptiform discharges, suggesting the remaining glu-
tamate transporter function present on astrocytes in the freeze
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lesion plays a significant role in glutamate handling. Because
glutamate transporters are only reduced in the lesion cortex
and not completely abolished, small changes in residual trans-
porters may play a significant role in glutamate accumulation in
response to stimulation leading to a larger neuronal response.
These small changes in residual transporters could result in
larger changes in network activation. Inhibition of glutamate
transporters may lead to further elevation in extracellular glu-
tamate levels in the more susceptible areas surrounding the
lesion leading to over-activation glutamate receptors and alter-
ation of other glutamate-mediated mechanisms. Furthermore,
glutamate independent mechanism not directly addressed here
may also play a role in the increased excitability including;
(1) changes in glial and neuronal morphology which mod-
ify the ECS and diffusion of glutamate and other excitatory
molecules; (2) neuronal TBOA-sensitive transporters which may
play a more significant role in the lesioned cortex; and (3) ele-
vated extracellular K+ which plays a significant role in neuronal
excitability.
GLUTAMATE TRANSPORTERS AND CORTICAL DYSPLASIA
Elevated levels of extracellular glutamate have been reported in
patients with epilepsy (During and Spencer, 1993; Cavus et al.,
2005). The results of studies examining glutamate transporter
expression in epilepsy are diverse. Increases and decreases in
transporter expression have been reported both in resections
from patients with epilepsy and in animal models (Mathern
et al., 1999; Meldrum et al., 1999; Crino et al., 2002; Proper
et al., 2002). Investigations of human temporal lobe epilepsy,
tuberous sclerosis and neocortical epilepsy reported an increase
in EAAC1 expression (Mathern et al., 1999; White et al., 2001;
Crino et al., 2002). In patients with cortical dysplasia, glu-
tamate transporters were differentially expressed in dysplastic
neurons compared to balloon cells (González-Martinez et al.,
2011). Expression of EAAC1 is decreased in the in utero MAM
cortical dysplasia model (Harrington et al., 2007). A consis-
tent pattern of change in glutamate transporters in epilepsy
has not been apparent in these studies using immunocyto-
chemistry and Western blotting. However, it is important to
note that these studies do not measure functional transporter
activity. Decreases in the ability to remove exogenously applied
glutamate, measured by glutamate biosensor imaging, have
been reported in freeze lesioned cortex (Dulla et al., 2012).
This result is consistent with our finding of reduced trans-
porter currents in astrocytes and suggests that functional alter-
ations in glial glutamate transporters occur in freeze lesioned
neocortex.
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